Regulation 287 Material about effects of medicinal product

United Kingdom

(1)

A person may not publish an advertisement relating to a medicinal product that suggests that the effects of taking the medicinal product—

(a)

are guaranteed;

(b)

are better than or equivalent to those of another identifiable treatment or medicinal product; or

(c)

are not accompanied by any adverse reaction.

(2)

A person may not publish an advertisement relating to a medicinal product that uses in terms that are misleading or likely to cause alarm pictorial representations of—

(a)

changes in the human body caused by disease or injury; or

(b)

the action of the medicinal product on the human body.

(3)

A person may not publish an advertisement relating to a medicinal product that refers in terms that are misleading or likely to cause alarm to claims of recovery.

(4)

A person may not publish an advertisement relating to a medicinal product that suggests that—

(a)

the health of a person who is not suffering from any disease or injury could be enhanced by taking the medicinal product; or

(b)

the health of a person could be affected by not taking the medicinal product.

(5)

Paragraph (4)(b) is subject to F1regulation 291A (campaigns relating to the suspected or confirmed spread of pathogenic agents etc.) and regulation 292 (exception for approved vaccination campaigns).

Annotations

Textual amendments

F1: Words in reg. 287(5) inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 22 and words in reg. 287(5) inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 22